Andrew Zhai

Andrew leads pharmacology studies that support the IND-enabling initiative at ProteinQure. He completed his PhD in Biochemistry at the University of Toronto with a postdoc at the Princess Margaret Cancer Centre. Previously, Andrew led small molecule discovery teams at Dalriada Drug Discovery.